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Abstract
Cyanide-resistant non-phosphorylating respiration is known in mitochondria from plants, fungi, and microorganisms but is
absent in mammals. It results from the activity of an alternative oxidase (AOX) that conveys electrons directly from the
respiratory chain (RC) ubiquinol pool to oxygen. AOX thus provides a bypath that releases constraints on the cytochrome
pathway and prevents the over-reduction of the ubiquinone pool, a major source of superoxide. RC dysfunctions and
deleterious superoxide overproduction are recurrent themes in human pathologies, ranging from neurodegenerative
diseases to cancer, and may be instrumental in ageing. Thus, preventing RC blockade and excess superoxide production by
means of AOX should be of considerable interest. However, because of its energy-dissipating properties, AOX might
produce deleterious effects of its own in mammals. Here we show that AOX can be safely expressed in the mouse (MitAOX),
with major physiological parameters being unaffected. It neither disrupted the activity of other RC components nor
decreased oxidative phosphorylation in isolated mitochondria. It conferred cyanide-resistance to mitochondrial substrate
oxidation and decreased reactive oxygen species (ROS) production upon RC blockade. Accordingly, AOX expression was
able to support cyanide-resistant respiration by intact organs and to afford prolonged protection against a lethal
concentration of gaseous cyanide in whole animals. Taken together, these results indicate that AOX expression in the
mouse is innocuous and permits to overcome a RC blockade, while reducing associated oxidative insult. Therefore, the
MitAOX mice represent a valuable tool in order to investigate the ability of AOX to counteract the panoply of mitochondrial-
inherited diseases originating from oxidative phosphorylation defects.
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Introduction
In mammalian mitochondria, the terminal step of electron
transfer to molecular oxygen, producing water, is exclusively
mediated by the cyanide-sensitive cytochrome c oxidase (COX) [1]
and the electron transfer is tightly coupled to proton translocation.
Protons simultaneously accumulated on the outer surface of the
inner membrane are subsequently used by the ATP synthase
(complex V, CV) to generate ATP from ADP and inorganic
phosphate imported in the mitochondrial matrix by the adenylate
carrier (Ant) and the phosphate carrier (Pic) respectively [2]
(Figure 1A). Usually, a small percentage of electrons escapes from
the RC to produce superoxide, with proposed roles in metabolic
signaling [3]. However, conditions leading to the over-reduction of
the ubiquinone pool may result in the production of excess
superoxide, with deleterious consequences [4,5]. In plants, many
microorganisms, and a few animals [6], a non proton-motive,
cyanide-resistant AOX, can also oxidize ubiquinol to produce
water [7] (Figure 1A), maintaining electron transfer even when the
activity of the cytochrome segment of the respiratory chain
(namely complex III to IV) is limiting or unavailable [8]. Under
such conditions, AOX also prevents the over-reduction of
ubiquinone, serving, in effect, an antioxidant role [9]. Crucially,
the enzymatic properties of AOX (low ubiquinol affinity) tend to
limit its involvement in respiration in vivo to conditions of
substantial over-reduction of the quinone pool, minimizing
detrimental competition with the phosphorylating cytochrome
pathway [10]. Nevertheless, in case of blockade of the cytochrome
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pathway, AOX enables divalent electron flow to oxygen, thus
acting as a safety valve to preserve respiration, restore metabolic
balance, and minimize excessive superoxide production [11].
Accordingly, we previously showed that Ciona intestinalis AOX
could be expressed in cultured human cells, conferring cyanide-
resistant respiration without harmful effects [12] and counteract-
ing the consequences of genetic defects in COX [13]. Similarly,
viable and active flies ubiquitously expressing AOX and substan-
tially resistant to the action of antimycin (a complex III-specific
inhibitor; Figure 1A) or cyanide were obtained [14]. AOX
expression in flies also rescued the lethality of genetically-induced
COX deficiency [14]. Altogether, these findings were an incentive
to attempt AOX expression in vivo in a mammal.
Here we show that the AOX can be expressed safely in a
mammal, without any obvious detrimental effect on major
physiological parameters. We show also that the presence of the
AOX conferred cyanide-resistance to mitochondrial substrate
oxidation and decreased ROS production under conditions of RC
inhibition. Importantly, the AOX also conferred cyanide-resis-
tance to intact organ respiration and significantly prolonged the
survival of the whole organism in the presence of this deadly
poison. Taken together, these results indicate that the AOX is
active in vivo in the MitAOX mouse and counteracts respiratory
chain blockade and its physiological consequences.
Results
The Ciona intestinalis AOX gene was recoded to maximize its
expression in the mouse and introduced into early mouse embryos
by germ-line lentiviral transduction on a mixed genetic back-
ground (CD-1/B6). We used the ubiquitously active, chimeric
CAG promoter, together with the Woodchuck hepatitis virus Post-
transcriptional Regulatory Element (WPRE) to further enhance
AOX gene expression (Figure 1B). PCR analysis of genomic DNA
up to the F3 generation indicated the presence of the AOX
transgene in all founder descendants. Copy number was estimated
by Southern blot at 4 to 8 per genome in the founders (Figure 1C).
Western blot analysis of the F3 generation brain mitochondria
indicated a consistent level of AOX protein between siblings
(Figure 1D). Litter size (1262 versus 1163 in control mice) was
unaffected by the presence of the transgene. A number of F3
individuals were analyzed for AOX distribution pattern. Western
blots indicated, similarly to F1 individual (Figure 2A), widespread
tissue expression, with expression prominent in brain and pancreas
and varying among different tissues (Figure 1E). We also checked
the stability of AOX expression as a function of age and observed
a preserved AOX expression in all the different tissues studied in
15 month-old animals (Figure 2A). We next showed that the
presence of the AOX did not alter the steady state levels of the
different RC complexes (Figure 2A–2B). Noticeably, AOX did not
require tight association with any of the RC complexes or
supercomplexes in order to be functional, since the enzyme was
not found associated with these entities in BN-PAGE analyses
(Figure 2C). AOX migrated as a dimer with an apparent
molecular weight of 70–72 kDa, with a substantial proportion
found as higher polymeric forms, mostly tetramer, or tending to
aggregate under this condition (6 g/g digitonin), as previously
observed in organisms where AOX is naturally present [15].
Finally, we showed that neither the distribution nor the quantities
of the RC supercomplexes were significantly modified by the
presence of the AOX (Figure 2D).
Detailed immunohistological analysis of highly AOX-expressing
tissues revealed differential expression depending on organ sub-
territories. For instance, in the pancreas, the pattern of AOX
expression matched that of complex III Core protein I (Core I)
and COX I (complex IV; not shown), being much higher in
exocrine than in endocrine tissue (insulin-producing Langerhans
islets; Figure 3A). In the brain (Figure 3B), AOX was massively
expressed in the CA3 pyramidal layer and the cortex, with a
perfect overlap with COX I (or Core I, or ATPase a (complex V);
not shown) antibody staining. AOX expression was lower in the
lateral amygdalar nucleus, even lower in the CA1 pyramidal layer,
and hardly detectable in the thalamus, the hypothalamus, or the
granule cell layer of the dentate gyrus, despite strong staining with
COX I (Figure 3B) or other OXPHOS marker antibodies (Core I,
ATPase a; not shown). Interestingly, immunohistological study
performed on the brain of WT and MitAOX mice using COX I
antibody revealed similar expression, which denotes the absence of
detectable effect of AOX expression on the amount and
distribution of mitochondria in the brain (Figure S1).
Mitochondria were next isolated from a number of tissues as to
investigate AOX functionality. A significant cyanide-resistant
oxidation of succinate was detected in several tissues and was
proportional to the AOX protein level. For instance, tissues with
the highest protein expression (brain and pancreas), showed the
highest cyanide resistance, which was less in heart and nearly
inexistent in liver (Figure 4A, traces a, c, e, g, h) with the lowest
protein level. In all cases, cyanide resistant respiration was fully
inhibited by 50 mM propylgallate (PG), a specific inhibitor of
AOX. A quite similar cyanide-resistance (about 30%) was
measured using malate plus glutamate as substrate (Figure 4A,
trace c). Noticeably, the oxidation of malate plus glutamate was still
efficiently controlled by the phosphorylation process in the
MitAOX mouse. This is shown by the large stimulation of malate
oxidation triggered by the ADP addition in the presence of
cyanide (Figure 4A, trace d).
Because AOX expression in the brain or in the pancreas
(Figure 3) was not uniform, the true extent of cyanide resistance in
AOX-expressing sub-territories in these tissues is presumably even
Author Summary
In mammalian mitochondria, the energy-producing ma-
chinery is powered by the electron transfer to molecular
oxygen, a mechanism whose terminal step is mediated by
the cyanide-sensitive cytochrome c oxidase (COX). In
plants, fungi, microorganisms, and some lower animals
(but not in mammals), in addition to the normal pathway, a
cyanide-resistant alternative oxidase (AOX) exists. It main-
tains electron transfer to oxygen even when the normal
pathway is blocked. This provides a bypath that releases
constraints on the energy producing machinery and
prevents the production of deleterious superoxide mole-
cules. Thus, preventing the energy producing machinery
blockade and excess superoxide production by means of
AOX should be of considerable interest. However, because
of its energy-dissipating properties, AOX might produce
deleterious effects of its own in mammals. Here we show
that the AOX can be safely expressed in a mammal with
major physiological and molecular parameters being
unaffected. We also show that the AOX is active in vivo
where it counteracts the energy producing machinery
blockade and reduces in vitro the associated oxidative
insult. Up to now, efficient therapies against mitochondrial-
associated diseases are lacking dramatically. Therefore, in
view of our results, the MitAOX mice represent a precious
tool to assess the AOX therapeutic capacity against the
panoply of inherited mitochondrial diseases.
MitAOX, the First Cyanide-Resistant Mammal
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higher. In comparison, whatever the substrate being oxidized
(succinate or malate) by mitochondria of WT animal tissues,
cyanide fully inhibited oxygen consumption (less ,1% resis-
tance to cyanide; Table S1). Afterwards, using a homemade
device supporting a nylon net, we were able to study the whole
organ respiration using the Clark oxygen electrode chamber. As
compared to WT, a significant cyanide-resistance of whole
organ respiration, 30% and 50% for brain hemisphere and optic
nerve respectively (Figure 4B, traces a–d) was observed in
MitAOX.
Figure 1. MitAOX mouse generation. A, an over simplified scheme of the respiratory chain featuring the alternative oxidase (AOX), inhibitable by
propylgallate (PG). Electron flow (green) from dehydrogenases (Complex II, CII; Complex I, CI) converges to reduce complex III (CIII) ubiquinone (Q)
pool, being channeled to oxygen through the respirasome, known to associate complexes I/III/IV in variable proportions. Over reduction of the Q
pool activates the AOX that hinders any overproduction of superoxide (red). B, Lentiviral genome containing the AOX-expressing cassette, randomly
integrated in the mouse genome (wavy lines). NcoI restriction enzyme was used to digest mouse tail genomic DNA. The blue box corresponds to the
cassette fragment used as a probe. C, Ectopic integrations quantification by Southern blot (b, d) and digestion profiles (a, c) for the two founders
(individuals 647 and 648) used to produce the 3 generations. D, Western blot analysis of F3 descendants from MitAOX founders 647, 648, showing the
consistent AOX expression level in the brain with a 1 to 2.2 ratio to the ßATPase-subunit signal. E, Quantification of AOX protein levels, shown in the
diagram, represents percentage of the expression in the highest expressing tissue (pancreas), based on signals from three MitAOX mice. F-Muscle,
femoral muscle; SCM-Muscle, sternocleidomastoid muscle; ON, optic nerve; Sa-Gland, salivary gland; Ad-Gland, adrenal gland.
doi:10.1371/journal.pgen.1003182.g001
MitAOX, the First Cyanide-Resistant Mammal
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Figure 2. Western-blot and BN-PAGE analyses of brain mitochondria from WT and AOX mice. A, Western-blot analyses of the steady
state of different RC complexes (CI, NDUFA12; CII, SDHA; CIII, Core1; CIV, Cox1 and, CV, ß-ATPase) of mitochondria extracted from 11 organs from four
WT and four AOX mice. B, RC complexes (I, III, IV and V) from three different organs, highly (brain), mildly (heart) and weakly (liver) expressing the
AOX, were quantified as a ratio to complex II with no significant difference being observed between WT and AOX mice. C, BN-PAGE analyses of cortex
mitochondria stained with antibodies raised against AOX, NDUFA9, Cox1 and SDHA, under non-denaturating conditions (6 g/g digitonin).
Supercomplex entities (three independent experiments) were found slightly but not significantly decreased in the MitAOX mice. D, Super-complexes
partial quantification based on supercomplex (CI/III2/IV) band relative to that of CII.
doi:10.1371/journal.pgen.1003182.g002
MitAOX, the First Cyanide-Resistant Mammal
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In order to estimate indirectly the participation of AOX in the
oxidation of succinate under phosphorylating conditions (presence
of ADP) we determined the ADP/O values in WT and MitAOX
mice brain mitochondria (Figure 5A). Any significant involvement
of the non-proton motive AOX in electron flow should decrease
the use of ADP associated with O2 consumption (Figure 1A),
thereby diminishing the ADP/O ratio. The measured values
(<1.4; Figure 5A) were found to be similar in MitAOX and WT
brain mitochondria, indicative of a negligible participation of
AOX in electron transfer in the presence of ADP, as previously
reported for mitochondria of organisms naturally endowed with
AOX [16]. Extensive investigations of brain and pancreas
mitochondria revealed no significant impact of AOX expression
on RC activities (Figure S2A). Because the low O2 level in vivo (i.e.
25 to 40 mM in the brain) might affect the activity of the AOX, we
next tested cyanide-resistance of substrate oxidation as a function
of O2 concentration (Figure 5B). We observed a gradual decrease
of cyanide-resistance only for O2 concentrations below 20 mM. At
these low oxygen tension values, percent of cyanide-resistance was
confirmed by the simultaneous measurement of oxygen consump-
tion in a closed chamber by a classical Clark electrode and a
fluorescence-based micro-optode (Figure S2B, S2C). AOX thus
appears to be fully functional under physiological conditions.
Interestingly, mitochondria from MitAOX mouse brain produced
significantly less ROS than their WT counterparts, despite partial
expression in the brain (Figure 3B). This was shown by an assay in
which superoxide, whose production was triggered by antimycin,
was fully converted to hydrogen peroxide (Figure 5C–5D).
Noticeably before the addition of antimycin, the limited produc-
tion of ROS is not affected by the presence of the AOX.
In order to evaluate a potential detrimental effect of AOX
expression, we next investigated a number of physiological and
behavioral variables in pups and mature MitAOX animals
(Table 1). Cardiorespiratory variables displayed minor, albeit
statistically significant differences between MitAOX and WT
newborn mice. In addition to their slightly smaller weights
(,10%), the MitAOX pups had slightly slower heart rates
(,8%) while minor differences in their breathing pattern did not
affect ventilation. Activity and ultrasonic vocalizations (a common
marker of anxiety in newborn rodents) showed no significant
genotype-related differences. Thus, the analysis of physiological
and behavioral variables in MitAOX newborn mice under normal
conditions did not reveal any pathological signs. Later on, at 3
months of age, MitAOX animals had similar weight and
performed as WT in the Rotarod test, documenting unaltered
motor coordination and fatigue resistance (Table 1), despite
significant AOX expression in the cerebellum and skeletal muscle
(Figure 1E).
Finally, in order to assess the capacity of the AOX to
compensate for a cytochrome pathway blockade in vivo, anesthe-
tized MitAOX mice were exposed to gaseous cyanide. The deadly
effect of cyanide on mammals has been previously shown to result
mostly from the inhibition of the mitochondrial cytochrome
oxidase rather than to its binding to other metalloenzymes [17].
Accordingly, we observed a substantially prolonged survival of
MitAOX mice in the presence of a lethal concentration of gaseous
cyanide, compared to WT mice (more than 200%). Moreover, by
using different transgenic founders with variable AOX expression,
we were able to show that the amount of resistance to cyanide in
the whole animal is proportional to AOX protein content as
determined in the lung and in the brain (Figure 5E).
Discussion
Our data show for the first time that a functional AOX can be
expressed in a mammal and transmitted between generations,
conferring significant cyanide-resistance to mitochondrial sub-
strate oxidation and tissue respiration as well as the whole
organism. As previously observed in cultured human cells [12,18]
and flies [14,19], the enzyme is targeted to the mitochondria
where it functionally interacts with the RC. Most importantly, our
data show that, similarly to the plant enzyme [8], the C. intestinalis
AOX expressed in the MitAOX does not interfere/compete
significantly with the cytochrome pathway, being functional only
upon blockade of this latter when the pool of ubiquinone becomes
highly reduced. Accordingly, the expression of the C. intestinalis
AOX in the mouse did not result in any deleterious consequence,
whilst spectacularly increasing the survival of the mouse in the
presence of a lethal concentration of gaseous cyanide. The
protective mechanism provided by the AOX to organisms
naturally harboring the enzyme was therefore fully preserved
when the oxidase was expressed in the mouse.
The AOX protein typically has such a high Km for reduced
quinones (apparent KmDQH2 from 0.53 to 0.38 mM) [20] that it
competes only very poorly with the cytochrome pathway (apparent
KmDQH2 less than 20 mM) [21] for quinol oxidation. In plants,
such a competition is further avoided by a specific channeling of
electrons, dictated by the structural association of the relevant
electron carriers, involving the malic enzyme, the Ndi (internal
rotenone-insensitive NADH dehydrogenase), and the AOX
proteins [22,23]. Noticeably, in the absence of Ndi in the
MitAOX mouse, the non proton-motive AOX can still promote
ATP formation through activation of NADH oxidation by the
proton-motive complex I.
The control of superoxide overproduction by AOX [24,25]
illustrates a second protective effect resulting from the AOX
expression in the mouse. According to our data, C intestinalis AOX
efficiently decreases superoxide overproduction triggered by the
over-reduction of the ubiquinone pool, which was generated by
antimycin. On the other hand, the innocuousness of AOX
expression in the mouse suggests that any production of
superoxide that is physiologically required [26,27] is not signifi-
cantly modified by the presence of a functional AOX in the
mitochondria.
The observed protection provided by the AOX against the toxic
effects of cyanide or antimycin, in the light of its expression
territories, should enable the use of the MitAOX mouse to testing
the potentially deleterious role of mitochondrial dysfunction and/
Figure 3. AOX expression territories in the pancreas and brain of the MitAOX mouse. A, Immunohistochemical study of MitAOX mouse
pancreas sections showing AOX protein distribution (green; a1, b1) in Langerhans islets (IL) and acinar cells (AC). AOX (a1) is especially noticed in
acinar cells where it perfectly overlaps with mitochondria stained by Core I antibody (red; a3). Despite the presence of numerous nuclei (a2) indicative
of a high cell number, AOX and Core I antibodies stained only faintly Langerhans Islets. Noticeably, AOX pancreatic expression did not hamper insulin
production by ß cells (b2), glucagon by a cells (c), or amylase in the exocrine pancreas (c). B, Immunohistochemical study of MitAOX brain showing
region-specific distribution of AOX (a) independently of cell density estimated by nuclei staining (b) and only partially overlapping the distribution of
mitochondria, stained with COX I antibody (c). Analyses (d–j) of brain regions (numbered according to b). AOX staining (d1–j1; green) overlaps
perfectly with COX I staining (d2–j2; red) in the cerebral cortex layer 2 and 6 (L2, L6), in the hippocampal region CA3 and in the lateral amygdalar
nucleus (d3–e3, j3; yellow). No AOX protein was convincingly detected in the thalamus, hypothalamus or striatum (g–i).
doi:10.1371/journal.pgen.1003182.g003
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Figure 4. Polarographic analysis of oxygen uptake in isolated mitochondria and intact organs. A, Mitochondrial substrate (succinate or
malate+glutamate) oxidation was strongly stimulated by ADP in mitochondria from all investigated tissues (a–h). A significant cyanide-resistant
oxidation was observed in brain (a–c) and pancreas (g) mitochondria of the MitAOX mouse and was fully inhibited by PG (a, c, d). Finally, a limited yet
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or the resulting oxidative stress in mouse models of neurodegen-
erative diseases [28]. It will be similarly interesting to use the
MitAOX mouse to investigate the potential role of mitochondrial
dysfunction and excess ROS production in ageing [29]. Indeed, a
single polypeptide, AOX, can replace two elaborate multisubunit
complexes (complexes III and IV; 11 and 13 subunits respectively),
without competing with these under normal conditions. AOX
expression may thus also chart a way to implementing a wide-
spectrum therapy for currently intractable but major disease
entities [11].
Finally, we may wonder why the AOX, with the huge metabolic
flexibility that it confers to the cell, has been lost in most of the
animal kingdom. One intriguing clue comes from the fact that
organisms naturally endowed with AOX are almost exclusively
sessile or pelagic, and their mitochondria must regularly endure
harsh energetic and stress conditions from which they cannot
escape: e.g., activation of photosynthesis for plants [30,31],
exposure to toxic xenobiotics for microorganisms, or local
fluctuations in the marine environment (temperature, oxygen,
nutrient levels) for animals that are fixed in one place [6]. In
contrast, in fast-moving organisms, AOX activity would only be
advantageous under peculiar conditions, such as those arising in
cases of mitochondrial diseases where OXPHOS is primarily or
secondarily affected. The creation of a mammal expressing the
AOX will surely be crucial in shedding light on this puzzling
evolutionary interrogation.
Materials and Methods
Animals
The mice were housed with a 12-h light/dark cycle and free
access to food (3% lipids, 16% protein; SAFE A-04 chow; UAR
Epinay sur Orge, France) and water. Animal management was in
accordance with Good Laboratory Practice Guidelines [32]. All
experiments were carried out following the recommendation of
INSERM for the use of animal laboratory and the approval by the
ethical committee of Debre-Bichat Hospitals; project number
2010-13/676-0014.
Construction of the AOX-Expressing Vector
The Ciona intestinalis AOX cDNA sequence [12] was redesigned,
optimized (AOXopt) in order to ameliorate its expression in mice
(DNA2.0 algorithm) and synthesized by DNA2.0 (Menlo Park,
CA, USA). The redesigned cDNA was flanked by the attL1/L2
recombination sites. Next, using Gateway cloning technology, the
AOXopt cDNA was transferred by an in vitro one-step recombi-
nation to the attR1/R2-containing plasmid pTrip [33], further
used to produce the AOX lentiviral vectors. Afterwards, the strong
chimeric CAG promoter was isolated as a 1.7 kb digestion
fragment (EcorV-Mlu1) from the p97 Vector and cloned upstream
the AOX in the pTrip-AOXopt vector, giving rise to pTrip-CAG-
AOXopt. Finally, the Woodchuck Hepatitis post-transcriptional
Regulatory Element (WPRE) was isolated as a 650 bp digestion
fragment (BstX1-Kpn1) from plasmid pT45 and introduced
downstream of the AOXopt cDNA, giving rise to the pTrip-
CAG-AOXopt-WPRE plasmid.
AOX Lentiviral Vector Production and Purification
Lentiviral vectors containing the CAG-AOXopt-WPRE con-
struct were generated as previously described [33]. Before
injection, the HIV p24 Gag antigen was quantified by ELISA
(HIV-1 P24 antigen assay; ZeptoMetrix corporation, NY, USA),
and the AOX-expressing lentiviral vectors were titered by
transducing 40,000 HeLa cells in 24-well plates with serial dilution
(2, 1, 0.5 ml). Each early mouse embryo was injected with 50–
500 pL (p24 vector titer: 109 ng/ml).
Genomic DNA Analysis
Mouse genomic DNA was extracted from frozen tail samples
using the MasterPure DNA Purification Kit according to the
manufacturer’s instructions (Tebu-Bio, Le Perray en Yveline,
France). The transmission of the AOX transgene was verified by
PCR on tail genomic DNA using AOXopt-F (GGATGAGCC-
CAATATCGAAG) and AOXopt-R (CTGAAACGAAAATG-
CCTTGG) primers. For Southern blot analysis the DIG System
from Roche Applied Science was used.
Protein Analysis
Western blot analyses were performed as indicated in [13]. In
addition, blots were re-probed with an anti-ßATPase (1:5000,
rabbit polyclonal antibody raised against the yeast ßATPase and
kindly provided by A. Tzagoloff) as a standardization control.
Peroxidase-conjugated anti-rabbit secondary antibody (1:5,000,
Amersham, Buckinghamshire, UK) was used at 5,000-fold
dilution. Blue-native PAGE (BN-PAGE) analyses were performed
on isolated mitochondria as described [34]. Concentration of
detergents as indicated in the figure legend.
Enzyme Activities
Respiratory chain enzyme activities were spectrophotometrical-
ly measured using a Cary 50 UV–visible spectrophotometer
(Varian Inc, Les Ulis, France) [35]. Mitochondrial substrate
oxidation was polarographically estimated using a Clark oxygen
electrode (Hansatech Instruments, Norfolk, England) in a mag-
netically-stirred chamber maintained at 37uC in 250 ml of a
respiratory medium consisting of 0.3 M mannitol, 5 mM KCl,
5 mM MgCl2, 10 mM phosphate buffer (pH 7.2) and 1 mg.ml
21
bovine serum albumin, plus substrates or inhibitors as described
[36]. Substrate and inhibitor concentrations were as followed:
1 mM ADP, 10 mM succinate, malate/glutamate (5 mM each),
1 mM KCN, 50 mM PG, 4 mM rotenone. Alternatively, oxygen
uptake was measured under similar condition using a micro-
optode consisting in an optic fiber equipped with an oxygen-
sensitive fluorescent terminal sensor (FireSting O2; Bionef, Paris,
France). Superoxide plus hydrogen peroxide production by isolated
brain mitochondria was quantified using Amplex Red fluorescence
in 1.5 ml of medium consisting of 125 mM KCl, 14 mM NaCl,
1 mM MgCl2, 20 mM EGTA, 4 mM KH2PO4 and 20 mM
significant cyanide-resistant succinate oxidation was measured in heart using 3 times more mitochondria (f). Cyanide-insensitive, PG-sensitive
substrate oxidation was never observed in wild-type mitochondria (not shown). Numbers along the traces are means of three independent replicates
and refer to nmol/min/mg protein. Mitochondrial protein: 100 to 150 mg. B, forebrain cerebral hemisphere (a, b) and optic nerve (c, d) respiration
from WT (a, c) and MitAOX (b, d) mice. Intact forebrain hemisphere was suspended in 1.5 ml of respiratory medium in the Clark oxygen electrode
chamber using a homemade device supporting a nylon net (200 mm mesh). Whole optic nerve was placed directly in the electrode chamber in 250 ml
of respiratory medium. Both brain and optic nerve respiration was found linear for more than K hour in the respiratory medium. Noticeably,
unspecific inhibitory effect of PG on WT and MitAOX tissue respiration (full inhibition of WT brain respiration) precluded the use of this inhibitor to
study tissue respiration.
doi:10.1371/journal.pgen.1003182.g004
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Figure 5. Consequences of AOX expression on mitochondrial properties in the MitAOX mouse. A, ADP/O values in cortex mitochondria
oxidizing succinate. Predicted value (grey) estimated for a 30% cyanide-resistant succinate oxidation (Figure 4A) and full operation of the AOX. B,
Oxygen uptake by 100 mg cortex mitochondria oxidizing 10 mM succinate in the presence of 500 mM ADP, in the absence (a) or presence (b) of KCN.
Numbers along the traces are nmol/min/mg protein Inset: cyanide-resistance plotted versus oxygen concentration. C, Simultaneous measurement of
oxygen consumption (a, c) and reduction of the Amplex Red dye (b, d) by 300 mg cortex mitochondria oxidizing succinate as described under
material and methods. Numbers along traces refer to oxygen uptake (a, c) or hydrogen peroxide (b, d) production. D, bar graph indicating the mean
value (four independent experiments) 6 SD of H2O2 production by WT and MitAOX brain mitochondria oxidizing succinate in the presence of
antimycin as in C. E, Anesthetized MitAOX and WT mice were exposed to cyanide and survival time noted. Expressed as a percent of WT mice survival
time, data for each MitAOX mouse tested were plotted as a function of AOX/ATPase protein levels in brain and lungs, quantitated from Western blots.
doi:10.1371/journal.pgen.1003182.g005
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HEPES (pH 7.2) to which were added 2 IU of purified superoxide
dismutase [37]. Inhibitory effect of propylgallate could not be
tested in these assays because of interactions with the probe.
Protein concentration was measured according to the Bradford
assay.
Immunohistochemistry
Brain analysis. Three-month-old mice were deeply anesthe-
tized with chloral hydrate (150 mg/kg i.p.) and perfused through
the ascending aorta with 20 ml of saline followed by 100 ml of 4%
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 (PB). Brains
were post-fixed overnight in 4% paraformaldehyde at 4uC,
cryoprotected in 30% sucrose in PB (4uC, 24 h) and frozen in
liquid isopentane at 245uC. Rabbit polyclonal anti-AOX
antibody (1:300), mouse monoclonal anti-Core1 (Core1; 1:300;
Fisher Scientific), and mouse anti-complex IV subunit I antibody
(COX I; 1:300; MitoSciences, Eugene OR, USA) were used for
double-labeling fluorescent immunohistochemistry and proceeded
as in [38].
Pancreas analysis. For pancreases, adult AOX transgenic
mice and WT mice were dissected and fixed in 10% formalin.
Sections (4 mm thickness) were collected and processed for
immunohistochemistry as described previously [39]. The antibod-
ies were used at the following dilutions: rabbit anti-AOX antibody
(1:500), mouse anti-Core 1 (1:500), rabbit anti-COX I (1:500). The
fluorescent secondary antibodies were Alexa 488-conjugated goat
anti-rabbit IgG (1:400) and Alexa 633-conugated goat anti-mouse
IgG (1:400) antibody (Fisher Scientific). Photographs were taken
using a fluorescence microscope Leica Leitz DMRB (Leica
Microsystemes, Nanterre, France) and a Hamamatsu C5810
cooled 3CCD camera (Hamamatsu Photonics, Hamamatsu City,
Japan). No signals were observed when the primary antibodies
were omitted.
Physiology
Breathing variables (breath duration (TTOT), tidal volume (VT),
and ventilation (VE) calculated as VT/TTOT) were measured
noninvasively in unanaesthetized, unrestrained 6-day old pups
using whole-body flow barometric plethysmography as described
previously [40,41]. Statistical analyses were performed using
Student’s t-test (Statview 5). Values of p,0.05 were considered
as significant. Motor coordination and fatigue resistance of older
animals (2 months) were assessed by Rotarod test as previously
described [42].
Mice Exposure to Inhaled Cyanide
Cyanide poisoning is classified as an USDA Pain and Distress
Category E condition, and the investigators estimated the study
acceptable only if the animals were beforehand anesthetized. The
investigators realized this might have impacted the outcome of the
experiment, but that without the use of anesthesia, the work would
have been inhumane. Mice were anesthetized with chloral hydrate
(350 mg/kg). Once anesthetized, one WT and one MitAOX
mouse were placed in a 5.2 L airtight acrylic glass chamber
maintained at 28uC (above the boiling point of cyanide, 26uC).
Cyanide gas (451 ppm) was produced in the chamber by injecting
100 mM KCN into a Petri dish containing 10 ml of 1 M sulfuric
acid. Respiratory activity of the mice was used as an index of
mouse survival. Four experiments were carried out with MitAOX
mice endowed with different levels of AOX, afterwards estimated
in the lung and the brain by Western blot analysis.
Supporting Information
Figure S1 Cox1 distribution profile in the MitAOX and WT
mice. Immunohistochemical study of MitAOX and WT brain
stained with COX I antibody showing mitochondrial distribution.
(TIF)
Figure S2 Respiratory chain activities and oxygen consumption
by WT and MitAOX mitochondria. A, Respiratory chain enzyme
activities from MitAOX and WT mice brain homogenates were
spectrophotometrically measured as described in materials and
methods. B, Oxygen consumption and cyanide resistance of
succinate oxidation by brain mitochondria from WT and
MitAOX mice measured using a standard Clark electrode (a) or
using a fluorescence-based micro-optode (b) as described under
material and methods. C, Effect of cyanide as a function of oxygen
tension under similar conditions measured with the micro-optode.
For the sake of comparison, slopes were adjusted by modulating
mitochondrial protein used to record oxygen consumption,
allowing an easier comparison of the effect of low oxygen tension.
(TIF)
Table S1 Polarographic determination of substrate oxidation
rates and cyanide resistance by brain or pancreas mitochondria.
Experimental conditions as described in Figure 4.
(DOCX)
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Table 1. Physiological variables in MitAOX and wild-type
mice.
Parameter MitAOX mice WT mice p-value
6 days of age*
Weight (g) 3.3260.41 3.6560.36 0.0067
Body temperature (uC) 36.660.3 36.360.1 0.0037
Activity duration (% time) 8.1169.08 9.6269.66 0.5954
Heart rate (beats min21) 483636 521647 0.0181
Ventilation (ml.s21.g21) 25.3264.05 23.5664.93 0.2006
Tidal volume (ml.g21) 7.6661.11 6.6061.23 0.0047
Breathing rate (breaths min21) 199631 214623 0.0774
Ultrasonic vocalisations (s) 0.5761.61 0.2660.48 0.4121
2 months of age
Weight (g): females (n = 9) 28.364.1 26.663.6 0.1444
Weight (g): males (n = 8) 36.363.8 32.363.6 0.1252
Latency to fall on the rotarod (s)
(n = 12)
143621 139656 0.8001
*At 6 days of age, cardiorespiratory variables of MitAOX (n = 23) and WT mice
(n = 21) were averaged over a 10 min period at 33uC. Activity duration is
expressed as percentage of total recording period (10 min). Duration of
ultrasonic vocalisations was totalized over 10 min. Values are group means
(6SD).
doi:10.1371/journal.pgen.1003182.t001
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